LETTER
Anthracycline-Induced Cardiotoxicity
Herman O. Klein, MD
15 May 1997 | Volume 126 Issue 10 | Page 827
TO THE EDITOR:
Missing from Shan and colleagues' interesting review of anthracycline-induced cardiotoxicity [1] is any reference to the potential use of L-carnitine to prevent adriamycin cardiotoxicity. Can the authors express their opinion? The beneficial effects of L-carnitine were reported by Anselmi and colleagues at the 31st Annual Meeting of the European Association of Pediatric Cardiologists.
|
Author and Article Information
|
|---|
Meir Hospital, Kfar-Saba, Israel
1. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996; 125:47-58.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
Author & Article Info
REFERENCE
Article
